Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹709.45
6.50 (0.92%)
High VOLATILITY
As on 10 Jul 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹6.43K Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
35.7
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹585+21.3%
52W High₹971-26.9%
Current Price
₹709.45
Circuit Limits (20%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹567.56
Upper Circuit₹851.34
Reference Price
₹709.45
Investment Checklist
Head and Shoulders on 1D (BREAKOUT CONFIRMED) — target ₹678.1
Head and Shoulders on 1D (BREAKOUT CONFIRMED) — target ₹628.4
Volume divergence: Bearish (price up, volume down)
SuperTrend(10,3): Price above SuperTrend (Industry Standard (Swing/Medium-Term))
SuperTrend(7,3): Price above SuperTrend (Responsive Setting (Day Trading/Short-Term))
Technical Analysis
Technical Analysis
Analysis from 2026-07-10
Confidence
44%
Trend
NEUTRAL
NEUTRAL
Mixed MA signals — sideways/transition
EMA20
687.93
EMA50
684.03
EMA200
739.31
Price Action
UPTREND
BULLISH
Higher Highs6
Higher Lows7
Lower Highs3
Lower Lows2
Support & Resistance Levels
Resistance (Above)
₹711.00
₹725.21
₹741.93
₹784.25
₹803.18
Support (Below)
₹694.00
₹687.05
₹670.88
₹624.55
₹604.15
Volume Analysis
TrendDECREASING
Change-49.90%
Unusual VolumeNo
Divergence Detected
Bearish (price up, volume down)
Stop Loss Levels
Fixed Risk
1% Risk₹702.36
3% Risk₹688.17
5% Risk₹673.98
7% Risk (Custom)
₹659.79Technical Levels
1x ATR (Volatility)₹685.29
2x ATR (Swing)₹661.13
3x ATR (Trend)₹636.97
Immediate Support₹694.00
Moving Averages
EMA 9 (Short-term)₹697.79
EMA 20 (Medium-term)₹687.93
EMA 50 (Trend)₹684.03
Financials
Financial Analysis
| Metric | Mar '25 | Jun '25 | Sep '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹534.7 Cr | ₹386.2 Cr | ₹418.3 Cr | ₹432.3 Cr |
| Net Profit | ₹88.3 Cr | ₹49.5 Cr | ₹27.9 Cr | ₹48 Cr |
| EPS | — | ₹5.46 | ₹3.08 | ₹5.29 |
| Operating Profit | ₹144 Cr | ₹95 Cr | ₹74.1 Cr | ₹104.1 Cr |
Peer Comparison
PharmaceuticalsPeer Comparison
Symbol | Name | Price | Change | P/E Ratio | Market Cap |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹1,935.50 | -0.17% | 40.2 | ₹4.64L Cr large Cap | |
| Divi's Laboratories Limited | ₹6,836.00 | +0.34% | 70.4 | ₹1.81L Cr large Cap | |
| Torrent Pharmaceuticals Limited | ₹4,901.50 | +0.07% | 77.5 | ₹1.66L Cr large Cap | |
| Cipla Limited | ₹1,439.40 | -0.13% | 30.1 | ₹1.16L Cr large Cap | |
| Zydus Lifesciences Limited | ₹1,150.80 | -0.71% | 23.0 | ₹1.16L Cr large Cap | |
| Lupin Limited | ₹2,496.30 | -0.28% | 21.4 | ₹1.14L Cr mid Cap | |
| Mankind Pharma Limited | ₹2,525.10 | -0.27% | 54.3 | ₹1.04L Cr mid Cap | |
| Dr. Reddy's Laboratories Limited | ₹1,244.30 | -1.99% | 25.6 | ₹1.04L Cr large Cap | |
| Aurobindo Pharma Limited | ₹1,564.70 | -1.43% | 26.1 | ₹90.88K Cr mid Cap | |
| Laurus Labs Limited | ₹1,537.80 | +2.02% | 91.5 | ₹83.02K Cr mid Cap | |
| Aarti Pharmalabs Limited | ₹709.45 | +0.92% | 35.7 | ₹6.43K Cr small Cap |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 16 Feb 2026 | Interim Dividend - Rs 1.50 Per Share | INTERIM_DIVIDEND |
| 15 Sept 2025 | Dividend - Rs 2.50 Per Share | DIVIDEND |
| 14 Feb 2025 | Interim Dividend - Rs 2.50 Per Share | INTERIM_DIVIDEND |
| 31 Jul 2024 | Dividend - Re 1 Per Share | DIVIDEND |
| 16 Feb 2024 | Interim Dividend - Rs 2 Per Share | INTERIM_DIVIDEND |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for AARTIPHARM
View AllNEWS
neutral
Business Standard - Markets 17d ago
Cohance Lifesciences Ltd leads gainers in 'A' group
Piramal Pharma Ltd, Jain Irrigation Systems Ltd, Aarti Pharmalabs Ltd and BASF India Ltd are among the other gainers in the BSE's 'A' group today, 23 June 2026.
AARTIINDAARTIPHARMBASFBSECOHANCEJISLDVREQSJISLJALEQSPOLYSILPPLPHARMARSYSTEMSCapital GoodsChemicals
NEWS
negative
Business Standard - Markets 45d ago
Techno Electric & Engineering Company Ltd leads losers in 'A' group
Container Corporation Of India Ltd, Poly Medicure Ltd, Aarti Pharmalabs Ltd and Le Travenues Technology Ltd are among the other losers in the BSE's 'A' group today, 26 May 2026.
AARTIINDAARTIPHARMBSECONCORHGINFRAIXIGOMBELPOLYMEDSALASARTECHNOECapital GoodsChemicals
positive
CNBC TV18 - Markets 45d ago
Aarti Pharmalabs Q4 Results: Shares slide 6% as forex loss, one-offs impact earnings performance
Aarti Pharmalabs recognised fair value losses related to a target redemption forward contract entered into during FY25 for hedging anticipating US dollar export inflows. The total fair value impact recognised in FY26 stood at ₹29.7 crore.
AARTIINDAARTIPHARMAONETMMQ50AONETOTALDOLLARTOTALVALUEChemicalsFinancial Services